Senior Medical Director, Clinical Development
Day One Biopharmaceuticals
I am trained as a pediatric neuro-oncologist and practiced for 12 years at Hasbro Children’s Hospital (Providence, RI) and Dana-Farber Cancer Institute (Boston, MA) and was involved in many academic phase 1-3 trials. In 2017, I left to join Pfizer as a medical director and became involved in the pediatric program running the pediatric Palbociclib phase 1-2 program. I went on to join a small biotech company (Repare Therapeutics) and was responsible for running multiple phase 1 trials in adult cancers with targeted therapies. I joined Day One Biopharmaceuticals in April of 2022 and am currently the medical lead for the tovorafenib program.
